Yayınlanmış 1 Ocak 2016 | Sürüm v1
Dergi makalesi Açık

A quantitative adaptation of the Wayne test for pyrazinamide resistance

  • 1. Asociac Benef PRISMA, San Miguel, Peru
  • 2. Univ Peruana Cayetano Heredia, Lima, Peru
  • 3. Univ Peruana Cayetano Heredia, Fac Sci, Res & Dev Labs, Lab TB Infect Dis, Lima, Peru

Açıklama

Background: Pyrazinamide (PZA) is the most important drug against the latent stage of tuberculosis (TB) and is used in both first and second line treatment regimens. The continued increase in multi-drug resistant TB and the prevalence of PZA resistance makes the development of alternative assays for prompt identification of PZA resistance all the more important.

Dosyalar

bib-815d4f44-42dc-4f08-9ca9-97464e642837.txt

Dosyalar (197 Bytes)

Ad Boyut Hepisini indir
md5:635f1fbb5c2d7ea92bae94b8e1f2745f
197 Bytes Ön İzleme İndir